SEC Form 5 · accession 0001209191-15-006541
Sage Therapeutics, Inc. · SAGE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Stephen Kanes
Officer — Chief Medical Officer
Period of report
Dec 31, 2014
Accepted (ET)
Jan 26, 2015 · 5:05 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001597553
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 28, 2014 | M | 60,186 | $0.45 | A | 63,186 | D | |
| Common Stock | Aug 28, 2014 | M | 1,162 | $1.36 | A | 64,348 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $0.45 | Aug 28, 2014 | M | 60,186 | D | — | Jul 18, 2023 | Common Stock | 60,186 | 162,036 | D |
| Stock Option (right to buy)F2 | $1.36 | Aug 28, 2014 | M | 1,162 | D | — | Jan 1, 2024 | Common Stock | 1,162 | 6,774 | D |
Explanation of responses
- F1The option, representing a right to purchase a total of 222,222 shares, became partially exercisable beginning on July 18, 2014. 25% of this option vested on July 18, 2014 and the remainder vests in equal monthly installments thereafter over 36 months.
- F2The option, representing a right to purchase a total of 7,936 shares, vests in equal monthly installments over 48 months beginning on January 1, 2014.